Type 2 Diabetes Market to 2019 - A
Shifting Treatment Algorithm and Intensified Competition Expected to Drive
Growth by 2019
GBI
Research has released its latest report for the pharmaceuticals industry, “Type
2 Diabetes Market to 2019 - A Shifting Treatment Algorithm and Intensified
Competition Expected to Drive Growth by 2019”. There is currently a large
number of blood glucose-lowering drugs in the crowded type 2 diabetes market
indicated for the treatment of chronically high blood glucose. The market is
led by Lantus, which achieved global sales amounting to $6.4 billion in 2012.
Over the forecast period from 2012 to 2019, the safer, more efficacious newer
classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are
expected to capture substantial market shares, largely replacing older classes
such as sulfonylureas and thiazolidinediones.
To
Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/type-2-diabetes-market-to-2019-a-shifting-treatment-algorithm-and-intensified-competition-expected-to-drive-growth-by-2019
Additionally,
a variety of novel drugs belonging to these newer classes are due to enter the
market, and are expected to offer a moderate improvement in terms of efficacy
and safety. The price of these new therapies is expected to be high, but this
is unlikely to hinder their uptake. As a result, as well as an overall increase
in the prevalent population, GBI Research believes that the value of the global
market has the potential to grow to reach $38.8 billion by 2019.
Scope
- A brief
introduction to type 2 diabetes, including the symptoms, pathogenesis,
risk factors and diagnosis
- In-depth
analysis of major glucose-lowering drugs for type 2 diabetes, including
analyses of their safety, efficacy, treatment patterns,
strengths/weaknesses and overall commercial prospects. Includes a heat map
comparing major drugs in terms of safety, efficacy and dosing parameters.
- Comprehensive
review of the pipeline for type 2 diabetes therapies, including individual
analysis of a number of late-stage pipeline drugs that are likely to enter
the market in the forecast period. The pipeline is analyzed on the basis
of phase distribution, molecule types and molecular targets.
- Additional
in-depth analysis of pipeline drug clinical trials by phase, molecule
type, trial size, trial duration and program failure rate analyses for
each molecule type and mechanism of action
- Multi-scenario
forecast data for the market up to 2019, taking into account how it will
be affected by the introduction of new drugs, the expiry of key patents on
current drugs, and changes in disease epidemiology across key developed
markets including the US, Japan, Germany, the UK, France, Italy and Spain
- Discussion of
the drivers and barriers for market growth
Reasons
to Buy
- Understand the
many different types of type 2 diabetes therapies on the market, from the
older, established classes of treatment to newer, moderately superior
types of drug, and their positions in the treatment algorithm
- Understand the
strengths and weaknesses of each product
- Understand the
scope of the pipeline, including which molecule types and mechanisms of
action are prominent
- Observe trends
in clinical trial duration and size amongst clinical phases and molecule
types, and use the clinical trial failure rate analysis to assess the risk
profiles of current and/or future developmental programs for type 2
diabetes therapeutics
- Assess the
potential clinical and commercial impact of current late-stage pipeline
molecules on the type 2 diabetes therapeutics market.
About
Us
Marketresearchreports.biz
is the most comprehensive collection of market research reports.
Marketresearchreports.biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
With a team of
experienced consultants we are committed to serve our clients in a way which
increase their efficiency, reduce costs and saves time. Our professional search
engine helps you in finding the best and latest market research report with
just one click of the mouse. Our database represents the most updates and
latest market research report collections form all the leading market research
publishers across the globe
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment